Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Roche Gets FDA Approval for New Advanced Melanoma Treatment

November 12, 2015 7:45 am | News | Comments

Today’s FDA approval is based on results from the Phase 3 coBRIM study. Read more...


Global Health Team Pioneers Development of New Antimalarial Drug Screening Model

November 12, 2015 7:30 am | by University of South Florida | News | Comments

The malaria parasite is becoming increasingly resistant to the drug artemisinin as the front-line treatment to combat the mosquito-borne disease. Read more...


World First Blood Cancer Drug Trial Reveals Life-Changing Results

November 12, 2015 7:15 am | by University of Leicester | News | Comments

The success story of this drug, has paved the way for its future development in combination studies, which will be opening to recruitment shortly in Leicester. Read more...


Canadian Researchers Improve Safety, Decreases Risk of New Blood Thinners

November 12, 2015 7:00 am | by McMaster University | News | Comments

Blood thinners are used to prevent and treat blood clots in a number of conditions including atrial fibrillation. Read more...


Novartis Heart Failure Medicine Entresto Cuts 30-day Hospital Readmissions, Analysis Shows

November 11, 2015 10:23 am | News | Comments

Novartis announced today data from a new analysis demonstrating that fewer heart failure patients with reduced ejection fraction (HFrEF) treated with Entresto (sacubitril/valsartan) tablets were readmitted to the hospital for heart failure or for any cause within 30 days of discharge from a heart failure hospitalization compared to patients treated with enalapril.  Read more...


Boehringer Ingelheim: Completed Enrollment of Phase 3 Trial for Biosimilar Candidate to Adalimumab

November 11, 2015 10:17 am | News | Comments

Boehringer Ingelheim today announced it has completed enrollment for the pivotal Phase 3 trial (NCT02137226) of BI695501, a biosimilar candidate to adalimumab (AbbVie's Humira). Read more...


Rare Her2 Mutations May Not Always Spur Breast Cancer on Their Own

November 11, 2015 10:08 am | by Johns Hopkins University | News | Comments

Results of a new laboratory study by Johns Hopkins Kimmel Cancer Center researchers suggests that some rare "missense" mutations in the HER2 gene are apparently not — on their own — capable of causing breast cancer growth or spread. Read more...


Nobelist Calls Macular Degeneration Trials “One of Most Successful” in Stem Cell Field

November 11, 2015 10:04 am | by Cynthia Fox, Science Editor | Articles | Comments

Clinical trials for what Nobel Prize-winner Sir John Gurdon, D.Phil., recently called “one of the most successful stem cell treatments so far” are cranking into second gear. Read more...


On Top of the Flu

November 11, 2015 10:01 am | by Harvard University | News | Comments

Harvard statisticians have devised a new method to track the flu via Internet search data, potentially providing public health officials and consumers alike with advance warning this flu season. Read more...


Express Scripts Sues Horizon, Fight Over Prescriptions Grows

November 11, 2015 9:48 am | by Tom Murphy, AP Business Writer | News | Comments

The drugmaker Horizon Pharma is questioning its relationship with an Express Scripts business after the pharmacy benefits giant sued Horizon for about $140 million and dumped a pharmacy that dispenses its drugs. Read more...


Renzi Plans to Invest $1.6B for Health Research Over Decade

November 11, 2015 8:50 am | by The Associated Press | News | Comments

Italian Premier Matteo Renzi is proposing a research center focused on improving human health at the former site of Expo 2015. Read more...


Teva Canada Announces Launch of Generic Version of (Pr)Avelox

November 11, 2015 8:46 am | News | Comments

The generic version treats adults with respiratory tract infections including acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis and community acquired pneumonia of mild to moderate severity. Read more...


Research Points to Development of Single Vaccine for Chikunguya, Related Viruses

November 11, 2015 8:41 am | by Washington University in St. Louis | News | Comments

The discovery, in mice, lays the groundwork for a single vaccine or antibody-based treatment against many different alphaviruses. Read more...


Computer Model Reveals Deadly Route of Ebola Outbreak

November 11, 2015 8:36 am | by Columbia University's Mailman School of Public Health | News | Comments

Their analysis uses data from the Sierra Leone Ministry of Health and Sanitation to chart the course of the Ebola outbreak. Read more...

US to Ask Canada, UK to Extradite Only Pharmacy Officials

November 11, 2015 8:31 am | by Matt Volz, Associated Press | News | Comments

U.S. prosecutors plan to ask the Canadian and British governments to extradite officials with an online pharmacy on charges of smuggling $78 million worth of mislabeled, unapproved and counterfeit cancer drugs. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.